1310 related articles for article (PubMed ID: 11012575)
21. Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome.
Norman RJ; Hague WM; Masters SC; Wang XJ
Hum Reprod; 1995 Sep; 10(9):2258-61. PubMed ID: 8530647
[TBL] [Abstract][Full Text] [Related]
22. Androgens in Cushing's Syndrome.
Arnaldi G; Martino M
Front Horm Res; 2019; 53():77-91. PubMed ID: 31499501
[TBL] [Abstract][Full Text] [Related]
23. The hypothalamo-pituitary-adrenal axis across the normal menstrual cycle and in polycystic ovary syndrome.
Stewart PM; Penn R; Holder R; Parton A; Ratcliffe JG; London DR
Clin Endocrinol (Oxf); 1993 Apr; 38(4):387-91. PubMed ID: 8391404
[TBL] [Abstract][Full Text] [Related]
24. Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries.
Fox R; Corrigan E; Thomas PG; Hull MG
Br J Obstet Gynaecol; 1991 Mar; 98(3):294-9. PubMed ID: 1827032
[TBL] [Abstract][Full Text] [Related]
25. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
Yang Z; Zhou W; Zhou C; Zhou Y; Liu X; Ding G; Hu Y; Pan J; Sheng J; Jin L; Huang H
J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681
[TBL] [Abstract][Full Text] [Related]
26. Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism?
Orio F; Palomba S; Cascella T; Tauchmanovà L; Di Biase S; Labella D; Russo T; Pellicano M; Savastano S; Zullo F; Lombardi G; Colao A
J Endocrinol Invest; 2004 Jan; 27(1):61-6. PubMed ID: 15053246
[TBL] [Abstract][Full Text] [Related]
27. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
Bidzińska B; Tworowska U; Demissie M; Milewicz A
Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
[TBL] [Abstract][Full Text] [Related]
28. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.
Newell-Price J; Trainer P; Perry L; Wass J; Grossman A; Besser M
Clin Endocrinol (Oxf); 1995 Nov; 43(5):545-50. PubMed ID: 8548938
[TBL] [Abstract][Full Text] [Related]
29. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
Lewandowski KC; Cajdler-Luba A; Bieńkiewicz M; Lewiński A
Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802
[TBL] [Abstract][Full Text] [Related]
30. A higher rate of hyperandrogenic disorders in female-to-male transsexuals.
Bosinski HA; Peter M; Bonatz G; Arndt R; Heidenreich M; Sippell WG; Wille R
Psychoneuroendocrinology; 1997 Jul; 22(5):361-80. PubMed ID: 9279941
[TBL] [Abstract][Full Text] [Related]
31. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
32. The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome.
Hahn S; Bering van Halteren W; Roesler S; Schmidt M; Kimmig R; Tan S; Mann K; Janssen OE
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):175-81. PubMed ID: 16705549
[TBL] [Abstract][Full Text] [Related]
33. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.
Carmina E; Wong L; Chang L; Paulson RJ; Sauer MV; Stanczyk FZ; Lobo RA
Hum Reprod; 1997 May; 12(5):905-9. PubMed ID: 9194637
[TBL] [Abstract][Full Text] [Related]
34. An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings.
Blunt SB; Sandler LM; Burrin JM; Joplin GF
Q J Med; 1990 Nov; 77(283):1113-33. PubMed ID: 2177207
[TBL] [Abstract][Full Text] [Related]
35. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?
Clayton RN; Ogden V; Hodgkinson J; Worswick L; Rodin DA; Dyer S; Meade TW
Clin Endocrinol (Oxf); 1992 Aug; 37(2):127-34. PubMed ID: 1395063
[TBL] [Abstract][Full Text] [Related]
36. Clinical and endocrine features of ultrasound diagnosed polycystic ovary patients: the correlation between ovarian volume and androgen activity.
Turhan NO; Senoz S; Gulekli B; Ozaksit G; Oral H; Gokmen O
J Pak Med Assoc; 1993 Jan; 43(1):4-6. PubMed ID: 8474219
[TBL] [Abstract][Full Text] [Related]
37. The adrenal cortex and virilization.
McKenna TJ; Cunningham SK; Loughlin T
Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
[TBL] [Abstract][Full Text] [Related]
38. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
Adams JM; Taylor AE; Crowley WF; Hall JE
J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
[TBL] [Abstract][Full Text] [Related]
39. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
al-Saadi N; Diederich S; Oelkers W
Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
[TBL] [Abstract][Full Text] [Related]
40. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.
Robinson S; Kiddy D; Gelding SV; Willis D; Niththyananthan R; Bush A; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1993 Sep; 39(3):351-5. PubMed ID: 8222298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
